With Roughly One in Twenty Augmented, Clinics Field the Middle Cases

LAGOS — At a Lumen Cognitive review clinic off the mainland bridge, neurologist Dr. Chidi Okafor spends his days not on the augmented who thrive or the ones who fail, but on the wide middle. With roughly one in twenty humans now carrying some neural or somatic augmentation, the clinic's queue is full of people who feel neither transformed nor harmed — only uncertain. "The public argument is all extremes," Okafor said, scrolling a consent form. "My patients live in the part nobody writes about." The Concordat's safety review of Somaform Augmetics's neural-interface line remains open and contested, with no finding cleared and none shipping, and the uncertainty has trickled down to the exam room: patients ask whether to wait, and Okafor has no data to tell them. Augmentation-rights advocates, including Somaform founder Julian Morrow, call the caution overdue diligence; critics call it paralysis. Between them sit the one-in-twenty, deciding one appointment at a time.